Corcept Therapeutics
CORT
#2401
Rank
A$9.62 B
Marketcap
$91.21
Share price
2.65%
Change (1 day)
146.04%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2024 (TTM): A$0.20 Billion

According to Corcept Therapeutics 's latest financial reports the company's current earnings are A$0.67 Billion. , an increase over its 2023 earnings that were of A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 A$0.21 B27.66%
2023 A$0.16 B-4.75%
2022 A$0.17 B-9.51%
2021 A$0.19 B-2.91%
2020 A$0.20 B14.87%
2019 A$0.17 B24.71%
2018 A$0.14 B69.32%
2017 A$83.11 M419.26%
2016 A$16 M-395.64%
2015 -A$5.42 Million-87.53%
2014 -A$43.44 Million-33.44%
2013 -A$65.26 Million
2011 -A$50.85 Million17.84%
2010 -A$43.15 Million35.5%
2009 -A$31.85 Million2.84%
2008 -A$30.97 Million60.81%
2007 -A$19.26 Million-52.14%
2006 -A$40.24 Million20.91%
2005 -A$33.28 Million31.87%
2004 -A$25.24 Million60.54%
2003 -A$15.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$27.42 B 12,635.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.18 Billion-6,218.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.45 B 9,859.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$19.94 B 9,159.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.47 B 8,014.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.35 B 15,384.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.8 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
A$47.99 M-77.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.85 B 295.59%๐Ÿ‡บ๐Ÿ‡ธ USA